Shares of Ardent Health, Inc. (NYSE:ARDT - Get Free Report) have earned an average rating of "Hold" from the fifteen ratings firms that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $12.79.
A number of research firms recently weighed in on ARDT. Wall Street Zen cut Ardent Health from a "buy" rating to a "hold" rating in a report on Sunday, July 12th. Truist Financial boosted their price objective on Ardent Health from $12.00 to $13.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. Leerink Partners reaffirmed an "outperform" rating and set a $14.00 target price on shares of Ardent Health in a research note on Friday, September 18th. Guggenheim increased their target price on Ardent Health from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. Finally, Zacks Research raised shares of Ardent Health from a "strong sell" rating to a "hold" rating in a research note on Monday, September 7th.
Check Out Our Latest Analysis on Ardent Health
Ardent Health Stock Up 3.6%
ARDT opened at $12.11 on Wednesday. The company has a fifty day moving average of $10.96 and a two-hundred day moving average of $10.23. The stock has a market capitalization of $1.71 billion, a price-to-earnings ratio of 22.02, a PEG ratio of 3.31 and a beta of 0.72. Ardent Health has a fifty-two week low of $7.71 and a fifty-two week high of $15.48. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.99 and a current ratio of 2.10.
Ardent Health (NYSE:ARDT - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). Ardent Health had a return on equity of 10.35% and a net margin of 1.22%. The firm had revenue of $1.62 billion for the quarter, compared to analysts' expectations of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, research analysts expect that Ardent Health will post 0.96 earnings per share for the current year.
Institutional Trading of Ardent Health
Institutional investors have recently modified their holdings of the stock. WINTON GROUP Ltd acquired a new position in shares of Ardent Health during the 2nd quarter worth about $124,000. Integrated Wealth Concepts LLC purchased a new stake in Ardent Health during the 2nd quarter worth approximately $57,000. Allworth Financial LP raised its holdings in shares of Ardent Health by 131.3% during the second quarter. Allworth Financial LP now owns 2,863 shares of the company's stock valued at $28,000 after acquiring an additional 1,625 shares during the last quarter. Corient Private Wealth LP acquired a new position in shares of Ardent Health during the second quarter valued at approximately $159,000. Finally, AXQ Capital LP lifted its position in shares of Ardent Health by 69.3% in the second quarter. AXQ Capital LP now owns 25,045 shares of the company's stock valued at $246,000 after acquiring an additional 10,249 shares in the last quarter.
About Ardent Health
(
Get Free Report)
Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women's health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.
The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.
Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.